Renaissance Technologies - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 33 filers reported holding SIGILON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$90
+38.5%
96,732
-47.7%
0.00%
Q4 2022$65
-99.9%
185,110
+18.4%
0.00%
Q3 2022$79,000
-58.2%
156,316
-31.5%
0.00%
Q2 2022$189,000
-53.3%
228,269
-17.2%
0.00%
Q1 2022$405,000
+23.5%
275,600
+131.8%
0.00%
Q4 2021$328,000
+97.6%
118,911
+305.8%
0.00%
Q3 2021$166,00029,3000.00%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 740,740$35,578,00013.90%
Flagship Pioneering Inc. 10,370,369$498,089,0009.07%
Monashee Investment Management LLC 561,628$26,975,0003.56%
SPHERA FUNDS MANAGEMENT LTD. 567,460$26,061,0002.31%
Avidity Partners Management LP 688,000$33,045,0001.07%
SECTORAL ASSET MANAGEMENT INC 225,000$10,807,0000.76%
Artal Group S.A. 276,000$13,256,0000.28%
GILDER GAGNON HOWE & CO LLC 662,227$31,807,0000.16%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$71,333,0000.11%
Perceptive Advisors 125,000$6,004,0000.06%
View complete list of SIGILON THERAPEUTICS INC shareholders